@MissMia1988 @SeivwrightTrudy That's why it's worth reading the whole thing... https://t.co/QCrZM2fUw9
@TBoyd81004365 @BenFish75 @SeivwrightTrudy No, this is what I already injected in my children: https://t.co/QCrZM2fUw9
@RTawneyJr @waynesonnichsen @Dlerxst @SeivwrightTrudy Yes, they studied it... https://t.co/QCrZM2fUw9
@MissMia1988 @SeivwrightTrudy No, it is not more dangerous, the study, all the other studies conducted on older children, the CDC and the American Academy of Pediatrics all agree. https://t.co/QCrZM2fUw9
@LieslMcconchie @HuffmanLabDU I was debating whether to delay the second dose for my 9yo boy, but decided he'd be better off reaching full protection sooner rather than later after reading this thread: https://t.co/pulk1tMFBi
@SMeerbeeck @aschatermees @keshy2020 @P_Bruijning U hebt volledig gelijk! Hier 'n stevige stuk advies, weloverwogen, beargumenteerd met referenties! https://t.co/3Bx1ZeslNJ
#Yoh_Yasushi_Check #新コロ 5-11歳のワクチン接種、CDCから。 The Advisory Committee on Immunization Practices’ Interim ... https://t.co/wyQRmJoBag @CDCgovより
The Advisory Committee on Immunization Practices’ Interim ... https://t.co/ssQ9Vn5ICS via @CDCgov #COVID
RT @A_Ra_Berlin: Публикация в MMWR с обоснованием рекомендаций спецкомиссии CDC к вакцинации детей от 5 до 11 лет вакциной BioNTech/Pfizer.…
The Advisory Committee on Immunization Practices’ Interim Recommendation: The Pfizer-BioNTech COVID-19 vaccine has high efficacy (>90%) against COVID-19 in children aged 5–11 years, and benefits outweigh risks for vaccination. https://t.co/4YsNpnjpCK
Публикация в MMWR с обоснованием рекомендаций спецкомиссии CDC к вакцинации детей от 5 до 11 лет вакциной BioNTech/Pfizer. По ссылке детали анализа пользы и риска с учетом фактических данных об известных и потенциальных преимуществах и рисках. https://t.co
For those who are interested in stats re #COVID19 weekly report. Covers child vaccination 5-18yrs and how global pandemic is still a major issue. https://t.co/wPqrVgORYb
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021 https://t.co/a35KXJ5v3x
La ACIP (comite asesor americano de vacunas) recomienda vacunación #covid a los niños 5 a 12 años. Argumento de la ACIP: Beneficios Vs efectos adversos en vacunados (0.07%) Vs placebo (0.10%) en el último gran estudio de Pfizer. https://t.co/OZcWO2gp98
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @andrewleedr: Advisory Committee on Immunization Practices’ Interim Recommendation for use of Pfizer-BioNTech COVID-19 vaccine in childr…
Advisory Committee on Immunization Practices’ Interim Recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 years 👉Vaccine has high efficacy (>90%) vs COVID-19 & their view is benefits outweigh risks for vaccination https
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
@loisrp @frozen Related: https://t.co/nmRGfEredr
Vaccini 5-11 anni, pubblicazione ACIP https://t.co/m3oljJDBxE
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
RT @ENirenberg: Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 wee…
Just a friendly reminder: there is no guidance to get the Pfizer vaccine for 5- to 11-year-olds at an interval beyond 3 weeks (21 days), despite claims otherwise: https://t.co/YsK43BbV6L https://t.co/1FhawPYyse
The Advisory Committee on Immunization Practices’ Interim ... https://t.co/FUWxNPFTzg vía @CDCgov
The Advisory Committee on Immunization Practices’ Interim ... https://t.co/ssQ9Vn5ICS via @CDCgov #COVID
Comirnaty becomes the first vaccine in the US to receive EUA in children, aged 5-11 years #COVID19 #Covidvaccine https://t.co/RHVxsdmVnd
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 | MMWR https://t.co/5NfRFm0vUR
Information by the CDC on vaccinating children. Click the link below for more information. @CBSDSchools @CBButlerElem #vaccination #VaccinateOurKids #StayHealthy #StaySafe
On November 2, 2021, after a systematic review of available data-recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 years in the United States for prevention of COVID-19.https://t.co/KHQ01c6S8q via @CDCgov
RT @KottonNelson: Hot off the press - The Advisory Committee on Immunization Practices’ Interim ... https://t.co/gLbRjycW8B via @CDCgov
RT @sergioassia: Va de nuevo por si no se habían enterado. Vacunen a sus hijos, completen sus esquemas.
RT @sergioassia: Va de nuevo por si no se habían enterado. Vacunen a sus hijos, completen sus esquemas.
RT @sergioassia: Va de nuevo por si no se habían enterado. Vacunen a sus hijos, completen sus esquemas.
RT @sergioassia: Va de nuevo por si no se habían enterado. Vacunen a sus hijos, completen sus esquemas.
So excited https://t.co/RSF5kycHc9
Va de nuevo por si no se habían enterado. Vacunen a sus hijos, completen sus esquemas.
RT @Ecole_Oubliee: 🚨Rapport qui présente les recommandations du Comité consultatif sur les pratiques d'immunisation (ACIP) pour Pfizer-BioN…
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 @cdcmmwr https://t.co/ew8C8E6oha
#Yoh_Yasushi_Check #新コロ #ワクチン 5-11歳、CDCからも。 The Advisory Committee on Immunization Practices’ Interim ... https://t.co/twEfRcnRud @CDCgovより
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years https://t.co/u5MWCYj5ae
"The Pfizer-BioNTech #COVID-19 vaccine has high efficacy (>90%) …in children aged 5–11 years, & benefits outweigh risks for vaccination. Vaccination is important to protect children against COVID-19 & reduce community transmission of #SARSCoV2"
🚨Rapport qui présente les recommandations du Comité consultatif sur les pratiques d'immunisation (ACIP) pour Pfizer-BioNTech #COVID19 Vaccin chez les enfants de 5 ans ─ 11. Rapport complet :https://t.co/ee1mFO5mjc
New CDC MMWR outlines recommendations from the Advisory Committee on Immunization Practices (ACIP) for Pfizer-BioNTech #COVID19 Vaccine in children ages 5─11. Full report: https://t.co/apXX5Q70kB https://t.co/RO3k3LHs6t
New MMWR from @CDCgov Interim recommendation for use of #Pfizer #COVID19 vaccine in children aged 5-11 years https://t.co/ndSzFSIB3R
RT @Bguge: The Advisory Committee on Immunization Practices’ Interim ... https://t.co/xa62O0ElSi via @CDCgov
The Advisory Committee on Immunization Practices’ Interim ... https://t.co/xa62O0ElSi via @CDCgov
RT @greg_folkers: ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, Nov…
RT @greg_folkers: ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, Nov…
RT @greg_folkers: ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, Nov…
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 https://t.co/P0kQ6pECOm https://t.co/7dDPuaa21m
Great news! The ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years. - protect against COVID-19 (sequelae) - reduce transmission - high efficacy (>90%) Finally, I will vaccinate my two little ones! htt
RT @KottonNelson: Hot off the press - The Advisory Committee on Immunization Practices’ Interim ... https://t.co/gLbRjycW8B via @CDCgov
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 #MMWR Early Release / November 5, 2021 / 70 via Centers…https://t.co/HeS6ZSshKy
RT @KottonNelson: Hot off the press - The Advisory Committee on Immunization Practices’ Interim ... https://t.co/gLbRjycW8B via @CDCgov